GSK3A
Glycogen synthase kinase-3 alpha
Also known as: GSK3A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P49840
- Gene
- GSK3A
- Ensembl
- ENSG00000105723
- Chromosome
- 19
- Canonical length
- 483 aa
- Protein class
- Cancer-related genes, Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene encodes a multifunctional Ser/Thr protein kinase that is implicated in the control of several regulatory proteins including glycogen synthase, and transcription factors, such as JUN. It also plays a role in the WNT and PI3K signaling pathways, as well as regulates the production of beta-amyloid peptides associated with Alzheimer's disease. [provided by RefSeq, Oct 2011]
Canonical amino-acid sequenceUniProt
483 residues, UniProt reviewed canonical sequence.
>P49840|GSK3A
1 MSGGGPSGGG PGGSGRARTS SFAEPGGGGG GGGGGPGGSA SGPGGTGGGK ASVGAMGGGV
61 GASSSGGGPG GSGGGGSGGP GAGTSFPPPG VKLGRDSGKV TTVVATLGQG PERSQEVAYT
121 DIKVIGNGSF GVVYQARLAE TRELVAIKKV LQDKRFKNRE LQIMRKLDHC NIVRLRYFFY
181 SSGEKKDELY LNLVLEYVPE TVYRVARHFT KAKLTIPILY VKVYMYQLFR SLAYIHSQGV
241 CHRDIKPQNL LVDPDTAVLK LCDFGSAKQL VRGEPNVSYI CSRYYRAPEL IFGATDYTSS
301 IDVWSAGCVL AELLLGQPIF PGDSGVDQLV EIIKVLGTPT REQIREMNPN YTEFKFPQIK
361 AHPWTKVFKS RTPPEAIALC SSLLEYTPSS RLSPLEACAH SFFDELRCLG TQLPNNRPLP
421 PLFNFSAGEL SIQPSLNAIL IPPHLRSPAG TTTLTPSSQA LTETPTSSDW QSTDATPTLT
481 NSSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GSK3A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 98 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 98 nTPM
- skeletal muscle: 80 nTPM
- cerebellum: 70 nTPM
- hippocampal formation: 63 nTPM
- amygdala: 62 nTPM
- basal ganglia: 57 nTPM
Single-cell type
- brain excitatory neurons: 16 nCPM
- other brain neurons: 16 nCPM
- late spermatids: 15 nCPM
- brain inhibitory neurons: 15 nCPM
- oligodendrocytes: 12 nCPM
- ependymal cells: 9 nCPM
Immune cell
- neutrophil: 1.7 nTPM
- eosinophil: 1.5 nTPM
- basophil: 0.9 nTPM
- MAIT T-cell: 0.9 nTPM
- intermediate monocyte: 0.8 nTPM
- naive CD8 T-cell: 0.8 nTPM
Brain region
- cerebral cortex: 198 nTPM
- white matter: 113 nTPM
- hippocampal formation: 98 nTPM
- pons: 93 nTPM
- basal ganglia: 93 nTPM
- thalamus: 93 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.13
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.22
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- autosome genomic imprinting
- beta-arrestin-dependent dopamine receptor signaling pathway
- cardiac left ventricle morphogenesis
- cell differentiation
- cell migration
- cellular response to glucocorticoid stimulus
- cellular response to insulin stimulus
- cellular response to interleukin-3
- cellular response to lithium ion
- excitatory postsynaptic potential
- extrinsic apoptotic signaling pathway
- extrinsic apoptotic signaling pathway in absence of ligand
- glycogen metabolic process
- insulin receptor signaling pathway
- lipopolysaccharide-mediated signaling pathway
- negative regulation of canonical Wnt signaling pathway
- negative regulation of cell growth involved in cardiac muscle cell development
- negative regulation of D-glucose import
- negative regulation of glycogen (starch) synthase activity
- negative regulation of glycogen biosynthetic process
- negative regulation of insulin receptor signaling pathway
- negative regulation of TOR signaling
- negative regulation of type B pancreatic cell development
- nervous system development
- positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway
- positive regulation of amyloid-beta formation
- positive regulation of autophagy
- positive regulation of gene expression
- positive regulation of heart contraction
- positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway
- positive regulation of neuron apoptotic process
- positive regulation of proteasomal ubiquitin-dependent protein catabolic process
- positive regulation of protein catabolic process
- positive regulation of protein targeting to mitochondrion
- positive regulation of protein ubiquitination
- positive regulation of substrate adhesion-dependent cell spreading
- positive regulation of transcription by RNA polymerase II
- proteasome-mediated ubiquitin-dependent protein catabolic process
- regulation of microtubule cytoskeleton organization
- regulation of mitophagy
- regulation of neuron projection development
- regulation of systemic arterial blood pressure
- viral protein processing
- Wnt signaling pathway
- positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway
Molecular functions
- ATP binding
- protein kinase A catalytic subunit binding
- protein serine kinase activity
- protein serine/threonine kinase activity
- signaling receptor binding
- tau protein binding
- tau-protein kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GSK3A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GSK3A as an antibody target. Whether an autoantibody or antibody against GSK3A could matter depends on whether native GSK3A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GSK3A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GSK3A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...